Delivery Order SPE2DB22D3004-SPE2DB25FPC65
Award Date
1/14/25
Potential Completion Date
2/5/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $13,246.00 for the supply of Esbriet 267 mg tablets. The contract, which has an ultimate completion date of October 16, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for providing medical supplies to the U.S. military. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract, valued at $3,311.50, is for the delivery of 4565220507 - Esbriet 801 mg tablet in quantities of 90s. The contract has an ultimate completion date of August 12, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract has a firm-fixed price of $3,311.50 and a completion date of November 5, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,277.85 Delivery Order contract is for the supply of Esbriet 801 mg tablets, a specialty medication. The contract has a firm fixed price pricing type and runs through December 24, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Esbriet 801 mg tablets in 90-count packages. The $3,311.50 firm-fixed-price delivery order is under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical...
This contract award is for the pharmaceutical product Esbriet 801 mg tablet, with 90 tablets per package. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is a delivery order with a firm fixed price of $3,425.95 and a completion date of January 6, 2025. The award was made on December 12, 2024, and there was no set-aside designation, indicating...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract provides for the delivery of 801 mg Esbriet tablets over a period ending on April 17, 2024, with a ceiling value of $3,311.50. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract, valued at $3,311.50, is a firm fixed-price delivery order with a completion date of November 27, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA). The $3,425.95 firm fixed price delivery order is for the product "ESBRIET 801 MG TABLET 90S" and has a completion date of March 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of pharmaceutical products, including Esbriet 267 mg capsules, to support federal healthcare programs. The award has a ceiling value of $2,771.25 and a completion date of October 17, 2022. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by...